Urology
Volume 68, Issue 2, Supplement , Pages 17-28, August 2006

Assessment of treatment outcomes in patients with overactive bladder: Importance of objective and subjective measures

  • Paul Abrams

      Affiliations

    • Bristol Urological Institute, Southmead General Hospital, Bristol, United Kingdom
    • Paul Abrams is a consultant/advisor for Pfizer Inc, Novartis, Ferring, and Plethora; a meeting participant/lecturer for Pfizer Inc, Novartis, Ferring, and Lilly; and participates in scientific studies/trials for Ferring, Plethora, and Lilly.
    • Corresponding Author InformationReprint requests: Paul Abrams, MD, Bristol Urological Institute, Southmead General Hospital, Westbury-On-Trym, Bristol, BS10 5NB, United Kingdom.
    • ,
  • Walter Artibani

      Affiliations

    • University of Padova, Padova, Italy
    • ,
  • Jerzy B. Gajewski

      Affiliations

    • Department of Urology, Dalhousie University, Halifax, Nova Scotia, Canada
    • Jerzy B. Gajewski is on a National Advisory Board for Pfizer Canada Inc., Eli Lilly Canada Inc., Bayer Inc., Janssen-Ortho, Sanofi-Synthelabo, Canada Inc., Allergan Inc., and Solvay Pharma Inc.; and an investigator for Medtronic, Pfizer Canada Inc., Eli Lilly Canada Inc., Bayer Inc., Janssen-Ortho, and Allergan Inc.
    • ,
  • Iqbal Hussain

      Affiliations

    • Pfizer Inc, New York, New York, USA
    • Iqbal Hussain was employed by Pfizer Inc.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(06)00772-2

doi:10.1016/j.urology.2006.05.044

Urology
Volume 68, Issue 2, Supplement , Pages 17-28, August 2006

Article Tools